Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Analysts at Zacks Research raised their Q3 2025 earnings per share (EPS) estimates for Teva Pharmaceutical Industries in a research report issued to clients and investors on Wednesday, May 1st. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of […]
Van ECK Associates Corp trimmed its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 14.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,942,442 shares of the company’s stock after selling 323,647 shares during […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) was the target of some unusual options trading on Tuesday. Stock traders purchased 33,848 call options on the company. This represents an increase of 52% compared to the average daily volume of 22,258 call options. Wall Street Analyst Weigh In Several equities analysts recently weighed in […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) was the recipient of some unusual options trading on Tuesday. Stock investors purchased 33,848 call options on the company. This is an increase of 52% compared to the typical volume of 22,258 call options. Insider Buying and Selling at Teva Pharmaceutical Industries In other news, CAO […]
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) and ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk. Earnings & Valuation This table compares Teva […]